This continuing education fills pharmacists' need to review both Alzheimer's disease pathophysiology and treatment options.
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict. The existence of relationships does not necessarily imply bias or lessen the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers. The relevant commercial financial relationships or affiliations must have occured over the past 12 months.
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity. Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
Requirements for CE Credit
Upon successful completion (70%) of the test and evaluation for this knowledge-based CE activity, 1.0 hour of continuing education credit will be awarded.
We wish to thank J. Mark Ruscin, Pharm. D, FCCP, BCPS for his expert opinion, Terri Poirier, Pharm. D, MPH, BCPS, FCCP, FASHP for her revision advice, and Walter Siganga, Ph.D. for his assistance and insights.
Survey research has indicated that pharmacists perceive that there is a need to educate themselves about Alzheimer’s Disease. The educational goal of this activity is to provide a comprehensive review of Alzheimer’s Disease risk factors and clinical features, recognition of pathophysiology, and recommendation of therapies.
- Identify Risk Factors for Alzheimer’s Disease
- Distinguish differences in Alzheimer’s Disease Pathophysiology
- Describe clinical features of Alzheimer’s Disease
- Outline an appropriate pharmacologic treatment plan for patients with Alzheimer’s Disease
- Describe appropriate secondary therapy for behavioral treatment in Alzheimer’s patients
Brief Bio : Jennifer is currently a fourth year pharmacy student at Southern Illinois University Edwardsville School of Pharmacy. She is scheduled to graduate in 2017.
Disclosure : Jennifer Huggins has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Brief Bio : Scott is currently a fourth year pharmacy student at Southern Illinois University Edwardsville School of Pharmacy. He is scheduled to graduate in 2017. At SIUE, I serve as the Class of 2017 President and the President of the Student Representative Council. In 2015 I was elected Student Trustee to the Society of Palliative Care Pharmacists. Working with the founders of an organization has been a one-of-a-kind experience. From designing logos to crafting mission and vision statements, I have been able to integrate myself into the beginnings of this new organization. Each of these positions have strengthened my leadership qualities and effectively prepared me for the future.
Disclosure : Scott Sexton has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Release Date: Nov 20, 2016
Credit Expiration Date: Nov 20, 2019